Eledon Pharmaceuticals, Inc. Common Stock (ELDN) is a publicly traded Healthcare sector company. As of May 21, 2026, ELDN trades at $3.88 with a market cap of $276.33M and a P/E ratio of -7.20. ELDN moved +6.98% today. Year to date, ELDN is +132.73%; over the trailing twelve months it is +25.49%. Its 52-week range spans $1.35 to $5.54. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces ELDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Eledon Pharmaceuticals, Inc. Common Stock (ELDN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ELDN moved +6.98% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.88 |
| Market Cap | $276.33M |
| P/E Ratio | -7.20 |
| EPS | $-0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.54 |
| 52-Week Low | $1.35 |
| Volume | 824.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.62M |
| Gross Margin | 0.00% |
3 analysts cover ELDN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.